Edesa Biotech, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Edesa Biotech, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2012 to Q3 2024.
  • Edesa Biotech, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $18.1M, a 9.77% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.1M +$1.61M +9.77% Sep 30, 2024 10-K 2024-12-13
Q3 2023 $16.5M +$1.37M +9.1% Sep 30, 2023 10-K 2024-12-13
Q3 2022 $15.1M +$3.47M +29.9% Sep 30, 2022 10-K 2023-12-15
Q3 2021 $11.6M +$3.45M +42.2% Sep 30, 2021 10-K 2022-12-16
Q3 2020 $8.17M +$1.82M +28.7% Sep 30, 2020 10-K 2021-12-28
Q3 2019 $6.35M -$5.76M -47.6% Sep 30, 2019 10-K 2020-12-07
Q4 2018 $737K Dec 31, 2018 10-KT 2019-12-12
Q3 2018 $12.1M -$253K -2.05% Sep 30, 2018 10-K 2018-11-30
Q3 2017 $12.4M +$2.05M +19.8% Sep 30, 2017 10-K 2018-11-30
Q3 2016 $10.3M +$2.05M +24.8% Sep 30, 2016 10-K 2017-12-01
Q3 2015 $8.27M +$1.4M +20.4% Sep 30, 2015 10-K 2017-12-01
Q3 2014 $6.87M +$2.24M +48.6% Sep 30, 2014 10-K 2016-12-14
Q3 2013 $4.62M +$1.13M +32.3% Aug 31, 2013 10-K 2015-12-14
Q3 2012 $3.49M Aug 31, 2012 10-K/A 2014-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.